sulfacur 100 mg ml oral liquid - search results

United States - English - NLM (National Library of Medicine)

sulfacetamide sodium solution

rebel distributors corp - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 ml - sulfacetamide sodium ophthalmic solution usp, 10% is indicated for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms, and as an adjunctive in systemic sulfonamide therapy of trachoma: escherichia coli, staphylococcus aureus, streptococcus pneumoniae, streptococcus (viridans group), haemophilus influenzae, klebsiella species, and enterobacter species. topically applied sulfonamides do not provide adequate coverage against neisseria species, serratia marcescens and pseudomonas aeruginosa. a significant percentage of staphylococcal isolates are completely resistant to sulfa drugs. sulfacetamide sodium ophthalmic solution is contraindicated in individuals who have a hypersensitivity to sulfonamides or to any ingredient of the preparation.

United States - English - NLM (National Library of Medicine)

sulfacetamide sodium- sulfacetamide sodium suspension

e. fougera & co. a division of fougera pharmaceuticals inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 ml - sulfacetamide sodium topical suspension usp, 10% is indicated in the topical treatment of acne vulgaris . sulfacetamide sodium topical suspension usp, 10% is contraindicated for use by patients having a known hypersensitivity to sulfonamides or any other component of this preparation (see warnings section).

United States - English - NLM (National Library of Medicine)

sulfacetamide sodium suspension

physicians total care, inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 ml - sulfacetamide sodium topical suspension usp, 10% is indicated in the topical treatment of acne vulgaris . sulfacetamide sodium topical suspension usp, 10% is contraindicated for use by patients having a known hypersensitivity to sulfonamides or any other component of this preparation (see warnings section).

United States - English - NLM (National Library of Medicine)

sulfacetamide sodium lotion

padagis israel pharmaceuticals ltd - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 ml - sulfacetamide sodium topical suspension usp, 10% (lotion) is indicated in the topical treatment of acne vulgaris . sulfacetamide sodium topical suspension usp, 10% (lotion) is contraindicated for use by patients having known hypersensitivity to sulfonamides or any other component of this preparation (see warnings section).

Canada - English - Health Canada

pms-sulfacetamide sodium liq 10% liquid

pharmascience inc - sulfacetamide sodium - liquid - 10% - sulfacetamide sodium 10% - antibacterials

Australia - English - Department of Health (Therapeutic Goods Administration)

epilim liquid sodium valproate 40 mg/ml sugar free oral liquid bottle

sanofi-aventis australia pty ltd - sodium valproate, quantity: 40 mg/ml - oral liquid - excipient ingredients: purified water; sorbitol solution (70 per cent) (non-crystallising); sodium methyl hydroxybenzoate; citric acid; brilliant scarlet 4r; hyetellose; sodium propyl hydroxybenzoate; saccharin sodium; flavour - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate

Australia - English - Department of Health (Therapeutic Goods Administration)

rifadin rifampicin 20mg/ml oral liquid bottle

sanofi-aventis australia pty ltd - rifampicin, quantity: 20 mg/ml - oral liquid - excipient ingredients: agar; sucrose; methyl hydroxybenzoate; propyl hydroxybenzoate; potassium sorbate; saccharin; polysorbate 80; diethanolamine; purified water; sodium metabisulfite; fragrance (perfume) - tuberculosis. in the initial treatment and in re-treatment of patients with tuberculosis, rifadin must be used in conjunction with at least one other antituberculosis drug. leprosy. in the management of lepromatous leprosy and dimorphous leprosy to effect speedy conversion of the infectious state to the noninfectious state, which may be expected to occur in 3 to 4 months of treatment. as an alterantive drug in lepromatous, dimorphous, indeterminate and tuberculoid leprosy resistant to sulfones and other antileprosy drugs. as an alternative drug in all those patients having true drug allergy to the more commonly used antileprosy drugs. meningococcal disease. prophylaxis of meningococcal disease in close contacts of known cases and in carriers. (rifadin is not indicated for the treatment of meningococcal infections). haemophilus influenzae. prophylaxis of household contacts of patients with h. influenzae type b.

United States - English - NLM (National Library of Medicine)

sodium sulfacetamide - sulfur wash- sodium sulfacetamide, sulfur liquid

acella pharmaceuticals - sulfacetamide (unii: 4965g3j0f5) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide 90 mg in 473.2 ml - indications: sodium sulfacetamide 9% - sulfur 4% wash is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications: sodium sulfacetamide 9% - sulfur 4% wash is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or ony other component of this preparation. sodium sulfacetamide 9% - sulfur 4% wash is not to be used by patients with kidney disease. pediatric use: safety and effectiveness in children under the age of 12 have not been established.

United States - English - NLM (National Library of Medicine)

sodium sulfacetamide 10 sulfur 5 cleanser- sulfacetamide sodium and sulfur rinse

acella pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 10 mg in 1 g - indications: sodium sulfacetamide 10% - sulfur 5% cleanser is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications: sodium sulfacetamide 10% - sulfur 5% cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sodium sulfacetamide 10% - sulfur 5% cleanser is not to be used by patients with kidney disease. pediatric use: safety and effectiveness in children under the age of 12 have not been established.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ozcrop metsulfuron 600 wg herbicide